Hydralazine hydrochloride
 OpenBabel02212023462D

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.1786   -0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1786    0.7219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5359    1.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2503    0.7219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2503   -0.1031    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5359   -0.5156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5359   -1.3406    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2503   -1.7531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8931    1.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6076    0.7219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6076   -0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8931   -0.5156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8468    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  1 12  1  0  0  0  0
  2  3  1  0  0  0  0
  2  9  1  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
M  END
>  <CdId>
921

>  <Mol Weight>
196.637

>  <Formula>
C8H9ClN4

>  <ID>
T1613

>  <Name>
Hydralazine hydrochloride

>  <Synonyms>
Apresoline

>  <CAS>
304-20-1

>  <Approved status>
FDA

>  <Disease>
Cardiovascular system

>  <Indication>
Heart Failure

>  <Pathways>
Metabolism

>  <Target>
MAO inhibitor

>  <Receptor>
AO

$$$$
